TM Bioscience shareholders and optionholders approve proposed acquisition by Luminex Corporation

27-Feb-2007

TM Bioscience Corporation announced that Tm Bioscience shareholders and optionholders have approved the acquisition of Tm Bioscience by Luminex Corporation at the Company's Special Meeting of shareholders and optionholders. Shareholders and optionholders representing more than 98 percent of all votes cast voted in favour of the transaction.

The approved merger will be submitted to the Ontario Superior Court of Justice for final court approval on or about February 27, 2007. If court approval is obtained and other customary conditions to closing are satisfied the transaction is expected to close on or about February 28, 2007, at which time all Tm Bioscience shareholders will be entitled to receive 0.06 Luminex common shares in exchange for each Tm Bioscience common share.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances